Herbicidal composition containing difluorobutenoic acid amide compound
US-2026007131-A1 · Jan 8, 2026 · US
1,2-Oxazines; Hydrogenated 1,2-oxazines
1,2-Oxazines; Hydrogenated 1,2-oxazines · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07D265/02 |
| Official title | 1,2-Oxazines; Hydrogenated 1,2-oxazines |
| Display label | 1,2-Oxazines; Hydrogenated 1,2-oxazines |
| Total patents | 39 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is rapidly growing.
| Year | Patents |
|---|---|
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 5 |
| 2021 | 3 |
| 2022 | 5 |
| 2023 | 1 |
| 2024 | 6 |
| 2025 | 7 |
| 2026 | 1 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Enantioselective process
US-12509417-B2 · Dec 30, 2025 · US
Substituted tetracycline compounds
US-2025388531-A1 · Dec 25, 2025 · US
Herbicidal compounds
US-12479804-B2 · Nov 25, 2025 · US
Nitrogen-containing heterocyclic compound having NRF2 activation effect
US-12441735-B2 · Oct 14, 2025 · US
Piperidinone derivative or salt thereof, harmful organism control agent containing said compound, and method for using same
US-2025185656-A1 · Jun 12, 2025 · US
Nitrogen-containing heterocyclic compound having nrf2 activation effect
US-2025171457-A1 · May 29, 2025 · US
Nitrogen-containing heterocyclic compound having nrf2 activation effect
US-2025084093-A1 · Mar 13, 2025 · US
Methods and compositions for decrosslinking biological samples
US-2024369459-A1 · Nov 7, 2024 · US
Covalent Inhibitors As Antiviral Agents
US-2024327334-A1 · Oct 3, 2024 · US
Fungicidal substituted heterocycles
US-2024308968-A1 · Sep 19, 2024 · US
Piperlongumine analogues and uses thereof
US-12084423-B2 · Sep 10, 2024 · US
Arylamide derivative having antitumor activity
US-2024246922-A1 · Jul 25, 2024 · US
Arylamide derivative having antitumor activity
US-11964950-B2 · Apr 23, 2024 · US
Arylamide derivative having antitumor activity
US-2023002333-A1 · Jan 5, 2023 · US
IL-6 inhibitors and methods of treatment
US-11530181-B2 · Dec 20, 2022 · US
Process and intermediates
US-11434192-B2 · Sep 6, 2022 · US
Herbicidal compounds
US-2022259153-A1 · Aug 18, 2022 · US
Lipophilic curcumin analogs and methods of inhibiting HIV-1, treating latent HIV in the brain, and preventing HIV-mediated cognitive decline and HIV dementia
US-11319273-B2 · May 3, 2022 · US
Enantioselective process
US-2022106263-A1 · Apr 7, 2022 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07D265/02?
- CPC C07D265/02 is the Cooperative Patent Classification code for “1,2-Oxazines; Hydrogenated 1,2-oxazines.”
- How many patents are filed under CPC C07D265/02 (1,2-Oxazines; Hydrogenated 1,2-oxazines)?
- Our database includes 39 publications tagged with this CPC code.
- Is patent activity under CPC C07D265/02 growing?
- Publication counts under this code: 6 in 2024 vs 7 in 2025 (latest complete years).